Hard-to-Treat Group Trips Up HCV Drug
(MedPage Today) — A promising hepatitis C medication has run into a roadblock in a small group of hard-to-treat patients, according to the drug’s maker.
(MedPage Today) — A promising hepatitis C medication has run into a roadblock in a small group of hard-to-treat patients, according to the drug’s maker.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.